Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Saniona´s CMO on the FDA’s Orphan Drug Designation for Tesomet in Prader-Willi Syndrome

Saniona yesterday announced that the FDA has granted Orphan Drug Designation (ODD) for the drug candidate Tesomet in the treatment of Prader-Willi syndrome (PWS). BioStock reached out to Rudolf Baumgartner, M.D., Chief Medical Officer and Head of Clinical Development at Saniona, to get his view on this important milestone and in what ways the ODD will help Saniona going forward.Read the full interview with Rudolf Baumgartner at biostock.se: https://www.biostock.se/en/sanionas-cmo-on-the-fdas-orphan-drug-designation-for-tesomet-in-prader-willi-syndrome/ This is a press release from

AFRY engineering partner when Renewcell expands operations to lead the fashion industry into a sustainable and circular future

Renewcell has awarded AFRY an engineering assignment for their recycled textile materials production expansion at SCA's Ortviken paper mill in Sundsvall, Sweden. The assignment includes project and construction management services, process, mechanical and piping engineering, electrical, automation and instrumentation engineering, fire and HVAC design, as well as civil design. The project is a continuation of AFRY's previous feasibility studies.The trend in textiles and design requires sustainable fashion. Customers require fashion companies to reduce their environmental impact through new

Saab publishes its Annual and Sustainability Report 2020

Saab’s annual and sustainability report for 2020 is as of today available on the Group’s website at www.saab.com.In the annual and sustainability report for 2020, more focus has been placed to showcase Saab’s purpose and role in society, and how the company aims to create greater value for all its stakeholders. This will be done by executing on our strategy in combination with continued investments in R&D and innovation, portfolio excellence, accelerated presence in strategic markets and by driving an active sustainability agenda. The annual report includes business cases and proof-points

Enterprising family get creative during lockdown

A mother and daughter studying at Staffordshire University have both set up successful businesses alongside their degrees during the coronavirus pandemic.June and Megan Evans have been busy crafting unique accessories and clothing at their family home in Middleton-by-Wirksworth, Derbyshire, for online shops that they each launched during the first national lockdown. June, 47, was a full-time mum to her three children before enrolling on the Art and Design foundation course at Staffordshire University and is now in her first year of the BA (Hons) 3D Designer Maker 

BioStock: CombiGene advances preclinically and recruits post-doc

On Monday, CombiGene announced that all quality analyses of the gene therapy drug candidate CG01 have been successfully completed prior to the final steps of the preclinical program. To secure important competence for the clinical program with CG01, which is planned for next year, Esbjörn Melin has been recruited to the position as industrial post-doc. BioStock contacted CombiGene’s CEO Jan Nilsson for a comment.Read the full interview with Jan Nilsson at biostock.se:  https://www.biostock.se/en/combigene-advances-preclinically-and-recruits-post-doc/ This is a pressrelease from

Notice of annual general meeting of H+H International A/S

The Board of Directors of H+H International A/S hereby invites the company’s shareholders to attend the annual general meeting of H+H International A/S on Friday 26 March 2021 at 10.00 am CET Due to the Covid-19 pandemic the Board of Directors has decided to hold the annual general meeting as a fully electronic general meeting without the possibility of physical attendance in accordance with section 1 of the Danish Executive Order no. 2240 of 29 December 2020, which due to the pandemic allows companies to conduct fully electronic general meetings regardless that the company’s Articles

Transaction for person discharging managerial responsibilities

CEO Michael T Andersen receives shares in H+H International A/S under matching share program from 2018 H+H International A/S has received notification pursuant to article 19 of EU Regulation no. 596/2014 of the below transaction(s) related to shares or other financial instruments in H+H International A/S made by persons discharging managerial responsibilities in H+H International A/S or persons closely related to them. 1. Details of the person discharging managerial responsibilities/person closely associated  a) Name: Michael Troensegaard Andersen 2. Reason for the notification

HL Display acquires Concept Group to further improve market leadership in UK

HL Display is acquiring Concept Group (Concept Data Display Ltd and Colour Display Ltd), an UK-based provider of retail solutions and services. The acquisition will strengthen HL’s offer and customer base and as a result HL’s position as a leading supplier for in-store merchandising and communication solutions to grocery retailers.HL Display is strengthening its market position in the UK through its acquisition of Concept Group. The company has 65 employees, with its head office and production site located in Leeds, UK. Annual sales are around £5.54m. Through over 30 years of experience in

Saab publishes its Annual and Sustainability Report 2020

Saab’s annual and sustainability report for 2020 is as of today available on the Group’s website at www.saab.com.In the annual and sustainability report for 2020, more focus has been placed to showcase Saab’s purpose and role in society, and how the company aims to create greater value for all its stakeholders. This will be done by executing on our strategy in combination with continued investments in R&D and innovation, portfolio excellence, accelerated presence in strategic markets and by driving an active sustainability agenda. The annual report includes business cases and proof-points

High tech meets cosy comfort in a Parisian clinic

Located in a quiet street in the 11th arrondissement in Paris, the entrance to Dr Esther Azoulay’s new clinic could easily go unnoticed. But the modesty stops at the threshold − once you enter, you immediately notice that the interior is quite out of the ordinary. With stone walls and skylight windows combined with the latest technology, the result manages to be both cosy and classy at the same time. “I wanted the clinic to reflect my personality,” says Dr Azoulay. “The space used to be a yoga studio, and I was looking to maintain its warmth and charm, but at the same time I

SKF invests SEK 400 million in Airasca, Italy

Gothenburg, 4 March 2021: SKF is investing SEK 400 million in expanding and modernizing its manufacturing facility in Airasca, Italy. The investment will bring the manufacturing of super-precision bearings (SuPBs) for industrial applications into the Group’s largest manufacturing site in Italy, through a significant new-build expansion.   As part of the investment, fully automated manufacturing channels for the production of SuPBs will be installed in Airasca. The first of these is expected to be operational during 2022. The investments in automated manufacturing processes will enable

Health technology company NewIcon outsources product development and engineering to Etteplan

Etteplan Press release March 4, 2021 at 12.00 noon EET Health technology company NewIcon that specializes in pharmacy automation systems outsources its product development and Engineering-to-Order functions to Etteplan. The outsourcing is part of NewIcon’s wider restructuring plan. According to the contract, four NewIcon’s specialist in Kuopio and Jyväskylä, Finland will transfer to Etteplan as existing employees as of March 1, 2021. ”NewIcon’s outsourcing strengthens Etteplans position and competences in health technology. I warmly welcome the product development and engineering

New microcomb could help discover exoplanets and detect diseases

Tiny photonic devices could be used to find new exoplanets, monitor our health, and make the internet more energy efficient. Researchers from Chalmers University of Technology, Sweden, now present a game changing microcomb that could bring advanced applications closer to reality.A microcomb is a photonic device capable of generating a myriad of optical frequencies – colours – on a tiny cavity known as microresonator. These colours are uniformly distributed so the microcomb behaves like a ‘ruler made of light’. The device can be used to measure or generate frequencies with extreme

Supplement to the stock exchange release: EAB Group Plc publishes its Annual Report, Corporate Governance Statement, Corporate Responsibility Report and Remuneration Report for 2020

EAB Group Plc, Stock Exchange Release, 4 March 2021, 11:30 a.m. (EET) Supplement to the stock exchange release: EAB Group Plc publishes its Annual Report, Corporate Governance Statement, Corporate Responsibility Report and Remuneration Report for 2020 EAB Group Plc has today, on 4 March 2021, published its Annual Report for the first time in accordance with European Single Electronic Format (ESEF) reporting requirements with the format of the report being Extensible Hypertext Markup Language (xHTML). In line with the ESEF requirements, the primary statements of the Consolidated

Dicot starts production of LIB-01 for human trials

Press release: Uppsala, March 4[th], 2021. The potency drug developer Dicot has started a new production of the drug candidate LIB-01. The batch will be used for the phase 1 human clinical trials starting in 2022.Dicot has just started a new production of the extract to be used for the drug candidate LIB-01. This is done in collaboration with Ardena in Södertälje, which is a certified CDMO (Contract Development & Manufacturing Organization). Ardena is an expert in managing the development and production of drug candidates and has, among other things, cutting-edge expertise in nano-medicine.

Update on the design of a Phase III Precision Medicine trial with the Diabetes Vaccine Diamyd®

The  upcoming Phase III trial with Diamyd[®] in new-onset type 1 diabetes will be based on the first precision medicine approach in the field. The trial is designed to confirm the effect and safety of Diamyd[®] in individuals recently diagnosed with type 1 diabetes who carry the genetic HLA DR3-DQ2 haplotype.The Phase III trial is designed to enroll approximately 330 individuals aged 12 to 28, recently diagnosed with type 1 diabetes, who carry the HLA DR3-DQ2 haplotype. This patient population is based on clinical efficacy and safety results from the Phase IIa and Phase IIb trials DIAGNODE-

AR Packaging fibre-based barrier tray for fresh vegetables and fruit minimises use of plastics

Fresh vegetables and fruit are food categories with high waste levels throughout the supply chain. To meet the move to packaging with less plastics while not sacrificing product protection, AR Packaging has introduced a barrier cartonboard tray with more than 95% fibre content, tailored barrier and convenience features.The drive to minimise the use of plastics in packaging is a main topic for retailers and food producer. Solid plastic trays are commonly used for fresh vegetables and fruits, and even if trays made of renewable plastics have been introduced, recyclable fibre trays are

IAR Systems announces availability of RISC-V development tools with certification for IEC 61508 and ISO 26262

The functional safety edition of IAR Embedded Workbench for RISC-V is certified by TÜV SÜD and delivers guaranteed support through the product life cycleUppsala, Sweden—March 4, 2021—IAR Systems®, the future-proof supplier of software tools and services for embedded development, announces the availability of a certified edition of its development toolchain for RISC-V. The functional safety edition of IAR Embedded Workbench® for RISC-V is certified by TÜV SÜD according to the requirements of IEC 61508, the international umbrella standard for functional safety, as well as ISO 26262, which is

Arcus ASA: Notice of The Annual General Meeting, 26 March 2021

Attached you will find the notice to the Annual General Meeting, including appendices. The notice is posted electronically or by mail to all shareholders. To help reduce the infection of COVID-19, all shareholders are encouraged to exercise their shareholder rights without physical attendance at the general meeting, either through online advance voting or by using the enclosed proxy form to provide a proxy to the Chairman (or the person he appoints) to vote at the general meeting. The Annual General Meeting can be followed via live broadcast at www.arcus.no/investor. There will not

Advenica receives order worth MSEK 6.7 from a Swedish authority

Advenica, the Swedish provider of cybersecurity solutions, has received a new order from a Swedish authority. The deal is worth MSEK 6.7, concerns services and deliveries will take place continuously until June 2022.Advenica is a well-established and trusted supplier of cybersecurity solutions that protect critical information - solutions that meet the highest security requirements. The company has now received a new order for services to ensure continued maintenance of quality and high assurance from a Swedish authority. Delivery of the order will begin immediately and will take place

How to enter the U.S. as a gaming B2B supplier

A new webinar from Internet Vikings entitled "How to enter the U.S. as a gaming B2B supplier" will be conducted on March 17 from 16:00 to 17:00 CET. Speakers of the webinar are co-founder and creative director of the Green Jade Games, Jesper Kärrbrink and head of U.S. expansion at Internet Vikings, Elena Kvakova. Together they will discuss various opportunities for gaming suppliers focusing on B2B marketing to scale to the American market. Keeping up the good work of conducting webinars, Internet Vikings announced their next event which will continue the series of webinars started

COMPLETE PROPOSALS FOR THE ANNUAL GENERAL MEETING

ANNOUNCEMENT NO. 57 – 4 MARCH 2021 4 March 2021 Below please find the complete proposals for the annual general meeting in Dampskibsselskabet NORDEN A/Sat 3.00 p.m. CET on Thursday 25 March 2021 see notice of 25 February 2021. The following proposals have been made: Re. item C on the agenda:  Proposed appropriation of profits or cover of loss in accordance with the adopted annual report.                           The Board of Directors proposes that profits be distributed as follows: DKK 9.0 in dividend per share of DKK 1 mUSD 60.5totalling

ExpreS2ion will participate at key industry and investor events in March 2021

ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will participate and hold presentations at key industry and investor events in March, all of which will be held digitally. These include Aktiespararna’s Aktiedagen (March 16), the St. Gallen International Breast Cancer Conference (March 17-21), and BIO-Europe Spring (March 22-25).By attending relevant industry and investor events, the company aims to increase the awareness of the ExpreS[2] technology platform and its exciting development pipeline, including the novel ES2B-C001 HER2-cVLP breast cancer

Helbio announce two new Patents

Metacon subsidiary Helbio is proud to announce that two pending Patent Applications filled with the United States Patent Office were approved. The patents are entitled” Catalytically heated fuel processor with replaceable structured supports bearing catalyst for fuel cells” and “ Heat integrated reformer with catalytic combustion for hydrogen production”. A continuation-in-patent application was also filled in the U.S. Patent office, based on the latter patent.These approved patents and related applications which were recently filled describe the heart of the Helbio advanced technology

There are no items matching the current filter
There are no more items matching the current filter
Back to top